Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 6Recruiting 3Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 340Neoplasms, Plasma Cell 62Lymphoma 38Recurrence 28Leukemia 26Lymphoma, Non-Hodgkin 22Leukemia, Myeloid, Acute 20Hodgkin Disease 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Myelodysplastic Syndromes 17Leukemia, Lymphocytic, Chronic, B-Cell 17Lymphoma, Follicular 16Lymphoma, Large B-Cell, Diffuse 15Immunoglobulin Light-chain Amyloidosis 14Lymphoma, B-Cell, Marginal Zone 13Hematologic Neoplasms 13Lymphoma, Mantle-Cell 12Burkitt Lymphoma 12Lymphoma, Large-Cell, Immunoblastic 10Neoplasms 8Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Leukemia, Myeloid, Accelerated Phase 8Blast Crisis 8Neoplasm, Residual 7Hematologic Diseases 7Pancreatic Neoplasms 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, B-Cell 6Lung Neoplasms 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Vascular Diseases × Plasma cell × Clear all
NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Celularity Incorporated

Phase 1 Unknown
29 enrolled
LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡